SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-010971
Filing Date
2024-08-06
Accepted
2024-08-06 09:20:47
Documents
48
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20240630x10q.htm   iXBRL 10-Q 1174733
2 EX-31.1 tmb-20240630xex31d1.htm EX-31.1 16121
3 EX-31.2 tmb-20240630xex31d2.htm EX-31.2 16129
4 EX-32.1 tmb-20240630xex32d1.htm EX-32.1 8277
5 EX-32.2 tmb-20240630xex32d2.htm EX-32.2 8839
  Complete submission text file 0001558370-24-010971.txt   4019844

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20240630.xsd EX-101.SCH 26017
7 EX-101.CAL tmb-20240630_cal.xml EX-101.CAL 18491
8 EX-101.DEF tmb-20240630_def.xml EX-101.DEF 100938
9 EX-101.LAB tmb-20240630_lab.xml EX-101.LAB 253755
10 EX-101.PRE tmb-20240630_pre.xml EX-101.PRE 188448
51 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240630x10q_htm.xml XML 494995
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Filer) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41264 | Film No.: 241177439
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)